Daw NC - Search Results

1

Telomerase expression predicts unfavorable outcome in osteosarcoma.

Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, Dome JS. Sanders RP, et al. Among authors: daw nc. J Clin Oncol. 2004 Sep 15;22(18):3790-7. doi: 10.1200/JCO.2004.03.043. J Clin Oncol. 2004. PMID: 15365076

2

Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma.

Rodriguez-Galindo C, Poquette CA, Daw NC, Tan M, Meyer WH, Cleveland JL. Rodriguez-Galindo C, et al. Among authors: daw nc. Med Pediatr Oncol. 2001 Jun;36(6):605-11. doi: 10.1002/mpo.1137. Med Pediatr Oncol. 2001. PMID: 11344491

3

Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.

Rodríguez-Galindo C, Daw NC, Kaste SC, Meyer WH, Dome JS, Pappo AS, Rao BN, Pratt CB. Rodríguez-Galindo C, et al. Among authors: daw nc. J Pediatr Hematol Oncol. 2002 May;24(4):250-5. doi: 10.1097/00043426-200205000-00006. J Pediatr Hematol Oncol. 2002. PMID: 11972091

4

Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.

Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, Billups CA, Wilimas JA. Dome JS, et al. Among authors: daw nc. J Pediatr Hematol Oncol. 2002 Mar-Apr;24(3):192-8. doi: 10.1097/00043426-200203000-00007. J Pediatr Hematol Oncol. 2002. PMID: 11990305 Clinical Trial.

5

Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children's Research Hospital experience.

Daw NC, Billups CA, Pappo AS, Jenkins JJ, Mahmoud HH, Krasin MJ, Rao BN. Daw NC, et al. Cancer. 2003 Jun 1;97(11):2839-47. doi: 10.1002/cncr.11384. Cancer. 2003. PMID: 12767098 Free article.

6

Giant cell tumor of bone with pulmonary metastases.

Okamoto Y, Mathew S, Daw NC, Neel MD, McCarville MB, Dome JS, Hill DA. Okamoto Y, et al. Among authors: daw nc. Med Pediatr Oncol. 2003 Nov;41(5):454-9. doi: 10.1002/mpo.10258. Med Pediatr Oncol. 2003. PMID: 14515387 No abstract available.

7

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors.

Daw NC, Santana VM, Iacono LC, Furman WL, Hawkins DR, Houghton PJ, Panetta JC, Gajjar AJ, Stewart CF. Daw NC, et al. J Clin Oncol. 2004 Mar 1;22(5):829-37. doi: 10.1200/JCO.2004.07.110. J Clin Oncol. 2004. PMID: 14990638 Clinical Trial.

8

High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.

Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC. Crews KR, et al. Among authors: daw nc. Cancer. 2004 Apr 15;100(8):1724-33. doi: 10.1002/cncr.20152. Cancer. 2004. PMID: 15073863 Free article. Clinical Trial.

9

Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000).

Rodriguez-Galindo C, Shah N, McCarville MB, Billups CA, Neel MN, Rao BN, Daw NC. Rodriguez-Galindo C, et al. Among authors: daw nc. Cancer. 2004 May 1;100(9):1928-35. doi: 10.1002/cncr.20214. Cancer. 2004. PMID: 15112274 Free article.

10

Adenocarcinoma of the cervix and vagina in pediatric patients.

McNall RY, Nowicki PD, Miller B, Billups CA, Liu T, Daw NC. McNall RY, et al. Among authors: daw nc. Pediatr Blood Cancer. 2004 Sep;43(3):289-94. doi: 10.1002/pbc.20113. Pediatr Blood Cancer. 2004. PMID: 15266416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters